Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|4|704-709

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.4, 2015-04, pp. : 704-709

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia

By  

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2482-2489

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preventive antibiotics in pediatric patients with acute myeloid leukemia (AML)

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 7, 2015-07 ,pp. : 1149-1154

John Wiley & Sons Inc

Access to resources Recommend Favorite

Family History and Relapse in Pediatric Acute Myeloid Leukemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 12, 2015-12 ,pp. : 2235-2237

John Wiley & Sons Inc

Access to resources Recommend Favorite

BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: A report from the Children's Oncology Group

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 4, 2014-04 ,pp. : 647-652

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gene Expression Profiling to Predict Viridans Group Streptococcal and Invasive Fungal Infection in Pediatric Acute Myeloid Leukemia: A Brief Report from the Children's Oncology Group

By  

Acta Haematologica, Vol. 131, Iss. 3, 2013-11 ,pp. : 167-169

Karger

Access to resources Recommend Favorite